Literature DB >> 34532523

Generation of Gene Knockout and Gene Replacement with Complete Removal of Full-length Endogenous Transcript Using CRISPR-Trap.

Jonas Mechtersheimer1, Stefan Reber1, Marc-David Ruepp1.   

Abstract

This protocol describes the application of the CRISPR-Trap from designing of the gene targeting strategy to validation of successfully edited clones that was validated on various human cell lines, among them human induced pluripotent stem cells (hiPSCs). The advantage of CRISPR-Trap over conventional approaches is the complete removal of any endogenous full-length transcript from the target gene. CRISPR-Trap is applicable for any target gene with no or little coding sequence in its first exon. Several human cell lines and different genes have so far been edited successfully with CRISPR-Trap.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  CRISPR; CRISPR-Trap; Gene editing; Gene knockout; Gene replacement; hiPSCs

Year:  2018        PMID: 34532523      PMCID: PMC8342058          DOI: 10.21769/BioProtoc.3052

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  6 in total

1.  Genome-wide discovery of human splicing branchpoints.

Authors:  Tim R Mercer; Michael B Clark; Stacey B Andersen; Marion E Brunck; Wilfried Haerty; Joanna Crawford; Ryan J Taft; Lars K Nielsen; Marcel E Dinger; John S Mattick
Journal:  Genome Res       Date:  2015-01-05       Impact factor: 9.043

2.  Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Authors:  Chen Yu; Yanxia Liu; Tianhua Ma; Kai Liu; Shaohua Xu; Yu Zhang; Honglei Liu; Marie La Russa; Min Xie; Sheng Ding; Lei S Qi
Journal:  Cell Stem Cell       Date:  2015-02-05       Impact factor: 24.633

3.  A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation.

Authors:  Isabel Aznarez; Yoseph Barash; Ofer Shai; David He; Julian Zielenski; Lap-Chee Tsui; John Parkinson; Brendan J Frey; Johanna M Rommens; Benjamin J Blencowe
Journal:  Genome Res       Date:  2008-05-02       Impact factor: 9.043

4.  Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.

Authors:  Stefan Reber; Jolanda Stettler; Giuseppe Filosa; Martino Colombo; Daniel Jutzi; Silvia C Lenzken; Christoph Schweingruber; Rémy Bruggmann; Angela Bachi; Silvia Ml Barabino; Oliver Mühlemann; Marc-David Ruepp
Journal:  EMBO J       Date:  2016-06-01       Impact factor: 11.598

5.  Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.

Authors:  Guoling Li; Xianwei Zhang; Cuili Zhong; Jianxin Mo; Rong Quan; Jie Yang; Dewu Liu; Zicong Li; Huaqiang Yang; Zhenfang Wu
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells.

Authors:  Stefan Reber; Jonas Mechtersheimer; Sofia Nasif; Julio Aguila Benitez; Martino Colombo; Michal Domanski; Daniel Jutzi; Eva Hedlund; Marc-David Ruepp
Journal:  Mol Biol Cell       Date:  2017-11-22       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.